Citadel Advisors
GDRX icon

Citadel Advisors’s GoodRx Holdings GDRX Stock Holding History

Citadel Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$152K Sell
77,400
-120,300
-61% -$282K ﹤0.01% 11669
2025
Q4 		$536K Buy
197,700
+161,000
+439% +$529K ﹤0.01% 8864
2025
Q3 		$155K Sell
36,700
-41,500
-53% -$182K ﹤0.01% 11509
2025
Q2 		$389K Sell
78,200
-65,100
-45% -$283K ﹤0.01% 9208
2025
Q1 		$632K Buy
143,300
+27,500
+24% +$129K ﹤0.01% 7961
2024
Q4 		$538K Buy
115,800
+58,100
+101% +$319K ﹤0.01% 8389
2024
Q3 		$400K Sell
57,700
-18,800
-25% -$148K ﹤0.01% 8716
2024
Q2 		$597K Buy
76,500
+3,900
+5% +$28.9K ﹤0.01% 7681
2024
Q1 		$515K Sell
72,600
-119,600
-62% -$791K ﹤0.01% 8323
2023
Q4 		$1.29M Sell
192,200
-99,600
-34% -$561K ﹤0.01% 6178
2023
Q3 		$1.64M Buy
291,800
+223,000
+324% +$1.49M ﹤0.01% 5571
2023
Q2 		$380K Sell
68,800
-9,400
-12% -$50.6K ﹤0.01% 8523
2023
Q1 		$489K Sell
78,200
-23,400
-23% -$130K ﹤0.01% 8376
2022
Q4 		$473K Sell
101,600
-31,100
-23% -$153K ﹤0.01% 8355
2022
Q3 		$620K Sell
132,700
-1,600
-1% -$10.1K ﹤0.01% 7993
2022
Q2 		$795K Sell
134,300
-39,000
-23% -$434K ﹤0.01% 7560
2022
Q1 		$3.35M Buy
173,300
+11,100
+7% +$255K ﹤0.01% 4958
2021
Q4 		$5.3M Sell
162,200
-2,300
-1% -$92.5K ﹤0.01% 4186
2021
Q3 		$6.75M Buy
164,500
+75,300
+84% +$2.73M ﹤0.01% 3746
2021
Q2 		$3.21M Sell
89,200
-198,200
-69% -$7.31M ﹤0.01% 5432
2021
Q1 		$11.2M Buy
287,400
+134,600
+88% +$6.05M ﹤0.01% 2813
2020
Q4 		$6.16M Buy
+152,800
New +$7.02M ﹤0.01% 3335

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Citadel Advisors's GDRX Position: Q1 2026 in Review

Citadel Advisors increased its GoodRx Holdings (GDRX) stake by 568% in Q1 2026, buying an estimated $454K and bringing the position to 227,583 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #9568.

Citadel Advisors first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $10.7M in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Citadel Advisors held 227,583 shares of GoodRx Holdings worth $446K as of Q1 2026.
  • Citadel Advisors bought 193,529 GoodRx Holdings shares in Q1 2026, an estimated $454K.
  • GoodRx Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9568 holding.
  • Citadel Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Citadel Advisors's GoodRx Holdings position peaked at $10.7M in Q2 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.